Target intelligence / Profile preview

PIN2 (TERF1) interacting telomerase inhibitor 1 (PINX1)

Target
PINX1
Molecular classification
Enzyme inhibitor, Chromatin/telomere-associated protein, Tumor suppressor, Other
01

Overview

PIN2 (TERF1) interacting telomerase inhibitor 1 (PINX1) is a nuclear protein that plays a crucial role in the negative regulation of telomerase activity and telomere length maintenance, contributing directly to chromosome stability and acting as a haploinsufficient tumor suppressor[1][2][4][6]. PINX1 binds to the telomerase catalytic subunit TERT and telomerase RNA component (hTR), thereby inhibiting the addition of telomeric repeats and preventing abnormal telomere elongation—a process frequently dysregulated in cancer[4][6]. Loss or reduction of PINX1 leads to increased telomerase activity, telomere lengthening, and chromosomal instability, which are hallmarks of many human cancers[4][6]. Conversely, overexpression of PINX1 can induce cellular crisis and enhance sensitivity to chemotherapeutic agents[4]. PINX1 is being explored both as a biomarker for cancer prognosis and a potential novel therapeutic target, mainly via modulation of telomerase and telomere dynamics[4][6].

Other names
PIN2/TERF1-interacting telomerase inhibitor 1Pin2-interacting protein 1PINX1_HUMANPINX1 geneHGNC:30046ENSG00000258724NCBI Gene:54984
02

Mechanism of action

- Inhibition of telomerase enzymatic activity (by direct interaction with TERT/hTR complex at telomeres) - Tumor suppressor function via restoration of normal telomere length and chromosomal stability - Sensitization of cancer cells to DNA-damaging agents/chemotherapeutics (by promoting crisis/cell death due to telomere dysfunction)

03

Biological functions

Telomerase inhibitionTelomere maintenanceChromosomal stabilityNegative regulation of cell proliferationTumor suppression
04

Disease associations

Cancer (notably hepatocellular carcinoma, breast cancer, and various epithelial malignancies)Chromosomal instability syndromesOther
05

Safety considerations

Potential off-target effects on normal stem cell telomere maintenance if PINX1-based inhibition is excessivePossible chromosome instability and cell viability loss in healthy tissues if over-inhibitedTumor suppressor loss-of-function is strongly associated with malignancy but not with safety of drug targeting PINX1
06

Interacting drugs

No small-molecule drugs directly approved or widely established for clinical use targeting PINX1 as of 2024; research ongoing on PINX1-based peptides and telomerase-targeted therapies (e.g., 5-fluorouracil may show enhanced effects with PINX1 overexpression)[4].
07

Biomarkers

PINX1 expression levels may serve as a biomarker for chromosomal instability, cancer progression risk, or response to telomerase-based therapies[6].Telomere length and telomerase activity (downstream markers)Loss or reduction in PINX1 expression in tumors

Beyond the preview

Go deeper on PIN2 (TERF1) interacting telomerase inhibitor 1 (PINX1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PIN2 (TERF1) interacting telomerase inhibitor 1 (PINX1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call